The Net Margin of Talis Biomedical Corp (TLIS) is -2905.67%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2023-12-31 | -2905.67% |
| 2022-12-31 | -2348.55% |
| 2021-12-31 | -2343.90% |
| 2020-12-31 | -833.15% |
| 2019-12-31 | -690.82% |
| 2018-12-31 | -892.76% |